Volume 13, Issue 4 (Vol.13 No.4 Jan 2025)                   rbmb.net 2025, 13(4): 590-597 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sistani Karampour N, Larti A, Sarahroodi S, Zaeemzadeh N. Morin Can Reduce Reserpine-induced Depression in Mice via Strengthening Antioxidant Defense. rbmb.net 2025; 13 (4) :590-597
URL: http://rbmb.net/article-1-1608-en.html
Morin Can Reduce Reserpine-induced Depression in Mice via Strengthening Antioxidant Defense
Neda Sistani Karampour , Ahmad Larti , Shadi Sarahroodi , Narjes Zaeemzadeh *
Department of Pharmacology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Abstract:   (184 Views)

Background: Depression is one of the most common mood disorders that greatly disrupt the lives of affected individuals. Due to the numerous side effects associated with chemical antidepressants, researchers have turned their attention to natural compounds. This study investigated the effects of Morin on Reserpine-induced depression in mice.

Methods: In this study, 48 male mice were divided into six groups. The Vehicle group received normal saline, while the negative and positive control groups received Reserpine (5 mg/kg) and Reserpine (5 mg/kg) + Fluoxetine (20 mg/kg), respectively. Eighteen hours after Reserpine injection, 50, 100, and 200 mg/kg Morin were administered to treatment groups. Forced swimming test (FST), tail suspension test (TST), and light-dark box tests were done as behavioral tests. Finally, brain tissue was isolated. The activity of Superoxide Dismutase enzyme and the levels of Reduced Glutathione and Malondialdehyde in the brain were measured.

Results: Morin could significantly increase the duration of activity in FST and TST in Reserpine-treated mice. In the light and dark box tests, Morin significantly decreased the latency to the first entry to the light chamber while increasing the number of entries and total time to last in the light chamber in Reserpine-treated mice. In the brain, Morin significantly enhanced the activity of the Superoxide Dismutase enzyme and the amount of “Reduced Glutathione” while reducing the levels of Malondialdehyde.

Conclusion: The results of this study demonstrate that Morin has a dose-dependent antidepressant effect by increasing the antioxidant capacity in the brains of rats.
 

Keywords: Depressive disorder, Morin, Oxidative Stress, Reserpine
Full-Text [PDF 401 kb]   (92 Downloads)    
Type of Article: Original Article | Subject: Biochemistry
Received: 2025/02/24 | Accepted: 2025/06/2 | Published: 2025/07/30
References
1. Dalgleish T, Power M. Handbook of cognition and emotion: John Wiley & Sons; 2000. [DOI:10.1002/0470013494]
2. Alford BA, Beck AT. Cognitive therapy of delusional beliefs. Behav Res Ther. 1994;32(3):369-80. [DOI:10.1016/0005-7967(94)90134-1] [PMID]
3. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10):1552-62. [DOI:10.1176/appi.ajp.157.10.1552] [PMID]
4. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in men. Am J Psychiatry. 2006;163(1):115-24. [DOI:10.1176/appi.ajp.163.1.115] [PMID]
5. Pan Y, Kong LD, Li YC, Xia X, Kung HF, Jiang FX. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacol Biochem Behav. 2007;87(1):130-40. [DOI:10.1016/j.pbb.2007.04.009] [PMID]
6. Satari A, Ghasemi S, Habtemariam S, Asgharian S, Lorigooini Z. Rutin: A Flavonoid as an Effective Sensitizer for Anticancer Therapy; Insights into Multifaceted Mechanisms and Applicability for Combination Therapy. Evid Based Complement Alternat Med. 2021;2021:9913179. [DOI:10.1155/2021/9913179] [PMID] []
7. Hosseinzadeh Samani B, Khoshtaghaza M, Minaee S, Abbasi S. Modeling the simultaneous effects of microwave and ultrasound treatments on sour cherry juice using response surface methodology. J Agr Sci Tech. 2015; 17: 837-846
8. Naismith SL, Longley WA, Scott EM, Hickie IB. Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry. 2007;7:32. [DOI:10.1186/1471-244X-7-32] [PMID] []
9. Lee RS, Hermens DF, Porter MA, Redoblado-Hodge MA. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. J Affect Disord. 2012;140(2):113-24. [DOI:10.1016/j.jad.2011.10.023] [PMID]
10. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet. 2010;42(9):759-63. [DOI:10.1038/ng.648] [PMID]
11. Caselli A, Cirri P, Santi A, Paoli P. Morin: A Promising Natural Drug. Curr Med Chem. 2016;23(8):774-91. [DOI:10.2174/0929867323666160106150821] [PMID]
12. Yu S, Liu X, Yu D, Changyong E, Yang J. Morin Protects LPS-Induced Mastitis via Inhibiting NLRP3 Inflammasome and NF-κB Signaling Pathways. Inflammation. 2020;43(4):1293-1303. [DOI:10.1007/s10753-020-01208-x] [PMID]
13. Nandhakumar R, Salini K, Niranjali Devaraj S. Morin augments anticarcinogenic and antiproliferative efficacy against 7, 12-dimethylbenz (a)-anthracene induced experimental mammary carcinogenesis. Mol Cell Biochem. 2012;364:79-92. [DOI:10.1007/s11010-011-1207-5] [PMID]
14. Verma VK, Malik S, Narayanan SP, Mutneja E, Sahu AK, Bhatia J, Arya DS. Role of MAPK/NF-κB pathway in cardioprotective effect of Morin in isoproterenol induced myocardial injury in rats. Mol Biol Rep. 2019;46(1):1139-1148. [DOI:10.1007/s11033-018-04575-9] [PMID]
15. Lorigooini Z, Ayatollahi SA, Amidi S, Kobarfard F. Evaluation of Anti-Platelet Aggregation Effect of Some Allium Species. Iran J Pharm Res. 2015;14(4):1225-31.
16. Rabiei Z, Mokhtari S, Babaei F, Rafieian-Kopaei M. Effect of Kombucha tea on depression and motor activity in mice. J Med Plants. 2017;16(61):156-166.
17. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977;229(2):327-336
18. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985;85(3):367-70. [DOI:10.1007/BF00428203] [PMID]
19. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980;13(2):167-70. [DOI:10.1016/0091-3057(80)90067-2] [PMID]
20. Hasan Anber ZN, Oied Saleh B, Hassan Majed R. Assessment of Oxidative Stress Parameters in Iraqi Male Patients with COVID-19; A Case Control Study. Rep Biochem Mol Biol. 2024;13(2):167-173. [DOI:10.61186/rbmb.13.2.167] [PMID] []
21. Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021; 20:689-709. [DOI:10.1038/s41573-021-00233-1] [PMID] []
22. Rawdin B, Mellon S, Dhabhar F, Epel E, Puterman E, Su Y, et al. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun. 2013;31:143-52. [DOI:10.1016/j.bbi.2012.11.011] [PMID] []
23. Perez-Caballero L, Torres-Sanchez S, Bravo L, Mico JA, Berrocoso E. Fluoxetine: a case history of its discovery and preclinical development. Expert opin drug discov. 2014;9(5):567-78. [DOI:10.1517/17460441.2014.907790] [PMID]
24. Mokini Z, Marcovecchio ML, Chiarelli F. Molecular pathology of oxidative stress in diabetic angiopathy: role of mitochondrial and cellular pathways. Diabetes Res Clin Pract. 2010;87(3):313-21. [DOI:10.1016/j.diabres.2009.11.018] [PMID]
25. Hassan MAM, Gad AM, Menze ET, Badary OA, El-Naga RN. Protective effects of Morin against depressive-like behavior prompted by chronic unpredictable mild stress in rats: Possible role of inflammasome-related pathways. Biochem Pharmacol. 2020;180:114140. [DOI:10.1016/j.bcp.2020.114140] [PMID]
26. Chen Y, Li Y, Xu H, Li G, Ma Y, Pang YJ. Morin mitigates oxidative stress, apoptosis and inflammation in cerebral ischemic rats. Afr J Tradit Complement Altern Med. 2017;14(2):348-55. [DOI:10.21010/ajtcam.v14i2.36] [PMID] []
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Reports of Biochemistry and Molecular Biology

Designed & Developed by : Yektaweb